CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 60 enrolled
Drug / intervention
PQ Bypass Stent Graft Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03128424
NCT03128424N/ACompleted
CompareCT.gov

Long Segment Lesion Peripheral Artery Revascularization Feasibility Study

Endologix·interventional·Posted Apr 25, 2017·Updated Oct 29, 2025

In Brief

A clinical study evaluating PQ Bypass Stent Graft System for Peripheral Arterial Disease. Completed, enrolled 60 participants.

Detailed Summary

The primary objective of the feasibility study is to evaluate the safety and effectiveness of the PQ Bypass Stent Graft System in the treatment of atherosclerotic lesions of the native superficial femoral artery (SFA) or the superficial femoral and proximal popliteal arteries.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPeripheral Arterial Disease
Countries--
CollaboratorsPQ Bypass, Inc.

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedApr 25, 2017
Enrollment StartFeb 1, 2016
Primary CompletionJul 1, 2020
Study CompletionSep 1, 2021
TodayJul 2, 2026
Enrollment to primary: 4.4 yearsPosted 9.2 years ago

Interventions

PQ Bypass Stent Graft Systemdevice

The PQ Bypass™ Stent Graft System is indicated to improve luminal diameter in the treatment of patients with symptomatic de novo or restenotic native lesions or occlusions of the superficial femoral artery (SFA) and/or proximal popliteal artery, with reference vessel diameters of 5.0 to 6.7 mm and lesion lengths up to 180 mm.